EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping

Sua Bae, Keyu Liu, Antonios N Pouliopoulos, Robin Ji, Sergio Jiménez-Gambín, Omid Yousefian, Alina R Kline-Schoder, Alec J Batts, Fotios N Tsitsos, Danae Kokossis, Akiva Mintz, Lawrence S Honig und 1 weitere

Theranostics · 2024 · 14 (11) · 4519-4535

DOI: 10.7150/thno.94206 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Theranostics, 2024. Verfasst von Sua Bae und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Columbia University, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Alzheimer Disease, Microbubbles, Magnetic Resonance Imaging. Die Arbeit wurde bisher 63-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Focused ultrasound (FUS) in combination with microbubbles has recently shown great promise in facilitating blood-brain barrier (BBB) opening for drug delivery and immunotherapy in Alzheimer's disease (AD). However, it is currently limited to systems integrated within the MRI suites or requiring post-surgical implants, thus restricting its widespread clinical adoption. In this pilot study, we investigate the clinical safety and feasibility of a portable, non-invasive neuronavigation-guided FUS (NgFUS) system with integrated real-time 2-D microbubble cavitation mapping.

Methods

A phase 1 clinical study with mild to moderate AD patients (N = 6) underwent a single session of microbubble-mediated NgFUS to induce transient BBB opening (BBBO). Microbubble activity under FUS was monitored with real-time 2-D cavitation maps and dosing to ensure the efficacy and safety of the NgFUS treatment. Post-operative MRI was used for BBB opening and closure confirmation as well as safety assessment. Changes in AD biomarker levels in both blood serum and extracellular vesicles (EVs) were evaluated, while changes in amyloid-beta (Aβ) load in the brain were assessed through 18F-florbetapir PET.

Results

BBBO was achieved in 5 out of 6 subjects with an average volume of 983 ± 626 mm3 following FUS at the right frontal lobe both in white and gray matter regions. The outpatient treatment was completed within 34.8 ± 10.7 min. Cavitation dose significantly correlated with the BBBO volume (R 2 > 0.9, N = 4), demonstrating the portable NgFUS system's capability of predicting opening volumes. The cavitation maps co-localized closely with the BBBO location, representing the first report of real-time transcranial 2-D cavitation mapping in the human brain. Larger opening volumes correlated with increased levels of AD biomarkers, including Aβ42 (R 2 = 0.74), Tau (R 2 = 0.95), and P-Tau181 (R 2 = 0.86), assayed in serum-derived EVs sampled 3 days after FUS (N = 5). From PET scans, subjects showed a lower Aβ load increase in the treated frontal lobe region compared to the contralateral region. Reduction in asymmetry standardized uptake value ratios (SUVR) correlated with the cavitation dose (R 2 > 0.9, N = 3). Clinical changes in the mini-mental state examination over 6 months were within the expected range of cognitive decline with no additional changes observed as a result of FUS.

Conclusion

We showed the safety and feasibility of this cost-effective and time-efficient portable NgFUS treatment for BBBO in AD patients with the first demonstration of real-time 2-D cavitation mapping. The cavitation dose correlated with BBBO volume, a slowed increase in pathology, and serum detection of AD proteins. Our study highlights the potential for accessible FUS treatment in AD, with or without drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierAlzheimer DiseaseMicrobubblesMagnetic Resonance ImagingHumansMaleAgedFemalePilot ProjectsAmyloid beta-PeptidesMiddle AgedBiomarkersDrug Delivery SystemsAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseaseblood-brain barriercavitation mappingfocused ultrasoundmicrobubbles

Substanzen

Amyloid beta-PeptidesBiomarkers

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Columbia University, New York, NY 10032, USA.
  • Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Department of Radiology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Department of Neurology and Taub Institute, Columbia University Irving Medical Center 10032, New York, NY, USA.

Förderung

  • NIA NIH HHS
  • NIBIB NIH HHS

Zitieren

APA

Bae, S., Liu, K., Pouliopoulos, A. N., Ji, R., Jiménez-Gambín, S., Yousefian, O., Kline-Schoder, A. R., Batts, A. J., Tsitsos, F. N., Kokossis, D., Mintz, A., Honig, L. S., & Konofagou, E. E. (2024). Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping. Theranostics, 14(11), 4519-4535. https://doi.org/10.7150/thno.94206

Vancouver

Bae S, Liu K, Pouliopoulos AN, Ji R, Jiménez-Gambín S, Yousefian O, et al. Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping. Theranostics. 2024;14(11):4519-4535. doi:10.7150/thno.94206

BibTeX
@article{Bae2024,
  author = {Bae, Sua and Liu, Keyu and Pouliopoulos, Antonios N and Ji, Robin and Jiménez-Gambín, Sergio and Yousefian, Omid and Kline-Schoder, Alina R and Batts, Alec J and Tsitsos, Fotios N and Kokossis, Danae and Mintz, Akiva and Honig, Lawrence S and Konofagou, Elisa E},
  title = {Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {4519--4535},
  doi = {10.7150/thno.94206}
}
Kostenlos starten →